Treatment with WTD increased LOC101928120 in the articular cartilage of rats with RA (p < 0.001 vs. sham group) and suppressed the increase of SHC1 mRNA and protein levels (p < 0.01 vs. the IL-1β group). The gene discussed is SHC1; the disease is rheumatoid arthritis.